Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
2001 1
2005 1
2007 2
2008 1
2009 1
2010 1
2012 1
2013 1
2014 1
2015 2
2016 1
2019 1
2020 1
2021 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Transarterial chemoembolization of unresectable renal cell carcinoma with doxorubicin-loaded CalliSpheres drug-eluting beads.
Bi Y, Shi X, Ren J, Yi M, Han X. Bi Y, et al. Sci Rep. 2022 May 17;12(1):8136. doi: 10.1038/s41598-022-12334-x. Sci Rep. 2022. PMID: 35581365 Free PMC article.
The safety and efficacy of drug-eluting beads transarterial chemoembolization (DEB-TACE) for unresectable renal cell carcinoma (RCC) still unknown. We aimed to assess the feasibility, safety and clinical efficacy of DEB-TACE with doxorubicin-loaded Cal …
The safety and efficacy of drug-eluting beads transarterial chemoembolization (DEB-TACE) for unresectable renal cell …
Current management of advanced and metastatic renal cell carcinoma.
Ather MH, Masood N, Siddiqui T. Ather MH, et al. Urol J. 2010 Winter;7(1):1-9. Urol J. 2010. PMID: 20209445 Free article. Review.
INTRODUCTION: Unresectable renal cell carcinoma (RCC) is a technically incurable condition. ...
INTRODUCTION: Unresectable renal cell carcinoma (RCC) is a technically incurable condition. ...
Targeted therapies in the treatment of advanced renal cell carcinoma.
Seront E, Machiels JP. Seront E, et al. Recent Pat Anticancer Drug Discov. 2009 Jun;4(2):146-56. doi: 10.2174/157489209788452803. Recent Pat Anticancer Drug Discov. 2009. PMID: 19519537 Review.
This paper provides a comprehensive review of the new targeted therapies currently available in clinical practice to treat patients with metastatic unresectable renal cell carcinoma. The relevant patents are discussed....
This paper provides a comprehensive review of the new targeted therapies currently available in clinical practice to treat patients with met …
Computed tomography characteristics of unresectable primary renal cell carcinoma treated with neoadjuvant sunitinib.
Salem ME, Shah SN, Elson P, Garcia JA, Wood LS, Medsinge A, Campbell S, Dreicer R, Rini BI. Salem ME, et al. Clin Genitourin Cancer. 2014 Apr;12(2):117-23. doi: 10.1016/j.clgc.2013.08.001. Epub 2013 Oct 12. Clin Genitourin Cancer. 2014. PMID: 24126239
Neoadjuvant sunitinib might downsize unresectable renal cell carcinoma (RCC) and enable nephrectomy in a subset of patients. ...
Neoadjuvant sunitinib might downsize unresectable renal cell carcinoma (RCC) and enable nephrectomy in a subset …
Transcatheter arterial embolization of unresectable renal cell carcinoma with a mixture of ethanol and iodized oil.
Park JH, Kim SH, Han JK, Chung JW, Han MC. Park JH, et al. Cardiovasc Intervent Radiol. 1994 Nov-Dec;17(6):323-7. doi: 10.1007/BF00203951. Cardiovasc Intervent Radiol. 1994. PMID: 7533666
PURPOSE: The effectiveness of renal transcatheter arterial embolization (TAE) with a mixture of ethanol and iodized oil (Lipiodol) was analyzed retrospectively in 27 patients with unresectable renal cell carcinoma. METHODS: Symptomatic or permanent pal …
PURPOSE: The effectiveness of renal transcatheter arterial embolization (TAE) with a mixture of ethanol and iodized oil (Lipiodol) was analy …
Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial.
Eisen T, Joensuu H, Nathan PD, Harper PG, Wojtukiewicz MZ, Nicholson S, Bahl A, Tomczak P, Pyrhonen S, Fife K, Bono P, Boxall J, Wagner A, Jeffers M, Lin T, Quinn DI. Eisen T, et al. Lancet Oncol. 2012 Oct;13(10):1055-62. doi: 10.1016/S1470-2045(12)70364-9. Epub 2012 Sep 6. Lancet Oncol. 2012. PMID: 22959186 Clinical Trial.
INTERPRETATION: Regorafenib has antitumour activity as first-line treatment for metastatic or unresectable renal-cell carcinoma. The drug's safety profile requires close monitoring....
INTERPRETATION: Regorafenib has antitumour activity as first-line treatment for metastatic or unresectable renal-cell …
17 results